3144A2-3004-WW
Laufzeit: 01.01.2009 - 31.12.2012
imported
Kurzfassung
A Randomized Double-Blind Placebo-controlled Trial of Nerafinib (HKI-272) After Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer
